DE69925312D1 - Bupropion zur behandlung von viralen erkrankungen - Google Patents

Bupropion zur behandlung von viralen erkrankungen

Info

Publication number
DE69925312D1
DE69925312D1 DE69925312T DE69925312T DE69925312D1 DE 69925312 D1 DE69925312 D1 DE 69925312D1 DE 69925312 T DE69925312 T DE 69925312T DE 69925312 T DE69925312 T DE 69925312T DE 69925312 D1 DE69925312 D1 DE 69925312D1
Authority
DE
Germany
Prior art keywords
treatment
bupropion
viral diseases
virus
hsv2
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69925312T
Other languages
English (en)
Other versions
DE69925312T2 (de
Inventor
Christopher William Reindler
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
PLANISPHERE CORP
Original Assignee
PLANISPHERE CORP
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by PLANISPHERE CORP filed Critical PLANISPHERE CORP
Application granted granted Critical
Publication of DE69925312D1 publication Critical patent/DE69925312D1/de
Publication of DE69925312T2 publication Critical patent/DE69925312T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Emergency Medicine (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE69925312T 1998-12-08 1999-12-07 Bupropion zur behandlung von viralen erkrankungen Expired - Fee Related DE69925312T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US13549498P 1998-12-08 1998-12-08
US135494P 1998-12-08
PCT/AU1999/001089 WO2000033827A1 (en) 1998-12-08 1999-12-07 Bupropion to treat viral diseases

Publications (2)

Publication Number Publication Date
DE69925312D1 true DE69925312D1 (de) 2005-06-16
DE69925312T2 DE69925312T2 (de) 2006-03-09

Family

ID=22468359

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69925312T Expired - Fee Related DE69925312T2 (de) 1998-12-08 1999-12-07 Bupropion zur behandlung von viralen erkrankungen

Country Status (14)

Country Link
US (2) US6512011B1 (de)
EP (1) EP1156791B1 (de)
JP (1) JP4166955B2 (de)
AT (1) ATE295159T1 (de)
AU (1) AU762624B2 (de)
BR (1) BR9916963A (de)
CA (1) CA2349487C (de)
DE (1) DE69925312T2 (de)
ES (1) ES2242438T3 (de)
HK (1) HK1042239B (de)
MX (1) MXPA01005725A (de)
NZ (1) NZ512716A (de)
PT (1) PT1156791E (de)
WO (1) WO2000033827A1 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030134905A1 (en) * 2002-01-11 2003-07-17 Reindler Christopher William Bupropion to treat viral diseases
DE102004063132A1 (de) * 2004-12-22 2006-07-06 Schmiegel, Wolff, Prof. Dr. Verwendung von Bupropion in Arzneimittel zur Behandlung von Hepatitis C
EP1896002A4 (de) 2005-06-27 2009-11-25 Biovail Lab Int Srl Bupropionsalzformulierungen mit modifizierter freisetzung
GB2477584A (en) * 2010-02-04 2011-08-10 Biocopea Ltd A compound for use in treating an acute viral infection
JP2013501770A (ja) * 2009-08-10 2013-01-17 バイオコピア リミテッド ウイルス感染症の治療
CN108721262A (zh) * 2017-04-13 2018-11-02 中国科学院武汉病毒研究所 安非他酮在制备治疗或预防流感病毒感染的药物中的应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4438138A (en) * 1982-12-06 1984-03-20 Burroughs Wellcome Co. Reduction of cholesterol with meta-chloro α-t-butylaminopropiophenone
US4507323A (en) * 1984-07-25 1985-03-26 Burroughs Wellcome Co. Treatment of psychosexual dysfunctions
US5753712A (en) * 1994-02-18 1998-05-19 Pinsker; Walter Treatment of migraine headaches and formulations
AUPN814496A0 (en) * 1996-02-19 1996-03-14 Monash University Dermal penetration enhancer

Also Published As

Publication number Publication date
BR9916963A (pt) 2002-03-05
ATE295159T1 (de) 2005-05-15
DE69925312T2 (de) 2006-03-09
ES2242438T3 (es) 2005-11-01
HK1042239B (zh) 2005-12-09
EP1156791A1 (de) 2001-11-28
CA2349487C (en) 2007-09-11
PT1156791E (pt) 2005-08-31
HK1042239A1 (en) 2002-08-09
EP1156791A4 (de) 2002-05-02
AU762624B2 (en) 2003-07-03
NZ512716A (en) 2003-10-31
WO2000033827A1 (en) 2000-06-15
CA2349487A1 (en) 2000-06-15
EP1156791B1 (de) 2005-05-11
US6512011B1 (en) 2003-01-28
JP2002531495A (ja) 2002-09-24
US20020173551A1 (en) 2002-11-21
JP4166955B2 (ja) 2008-10-15
AU1762900A (en) 2000-06-26
MXPA01005725A (es) 2003-07-14

Similar Documents

Publication Publication Date Title
UA56989C2 (uk) ФІЗІОЛОГІЧНО АКТИВНИЙ ПЕГ-КОН'ЮГАТ <font face="Symbol">a</font>-ІНТЕРФЕРОНУ, СПОСІБ ЙОГО ОДЕРЖАННЯ, ФАРМАЦЕВТИЧНА КОМПОЗИЦІЯ НА ЙОГО ОСНОВІ ТА СПОСІБ ЛІКУВАННЯ АБО ПРОФІЛАКТИКИ ІМУНОМОДУЛЯТОРНИХ ЗАХВОРЮВАНЬ
IL157504A0 (en) Oncolytic virus therapy
ATE179888T1 (de) Ophthalmische zubereitung zur behandlung oder prävention von trockenem auge und krankheiten, die dadurch verursacht werden, enthaltend 12- sulfodehydroabietsäure
DE60030732D1 (de) Verwendung von 2-amino-2-(2-(4-octylphenyl)ethyl)propane-1,3-diol zur prävention oder behandlung viraler myocarditis
DE69925312D1 (de) Bupropion zur behandlung von viralen erkrankungen
ZA991749B (en) Pharmaceutical composition for prophylaxis and therapy of diseases associated with ocular fundus tissue cytopathy.
PT1237562E (pt) Processo de preparacao de extractos de micania contendo micanolida e di-hidromicanolida e utilizacao no tratamento das doencas proliferativas
ATE316379T1 (de) Oxyhuminsäure und ihre verwendung zur behandlung von verschiedenenen störungen
ATE78168T1 (de) Arzneimittelzusammensetzung zur vorbeugung und behandlung bakterieller und viraler krankheiten.
MY124071A (en) Treatment of viral disease in swine
ITMI913493A0 (it) Dispositivo per la disinfezione o la immunizzazione di zone del corpo umano esposte al contagio, da germi, batteri e virus
WO1997026880A3 (en) Use of a combination of delavirdine and one or more protease inhibitors in hiv-1 infected patients
HUP9700975A2 (hu) Élő, legyengített, Pasteurellaceae családba tartozó, RTX-termelő baktériumok
ATE207353T1 (de) Verwendung von benzydamin zur behandlung von krankheitszuständen, die durch tnf verursacht werden
IL112183A0 (en) Use of bradykinin antagonists for the preparation of medicaments for the treatment of virus diseases
ATE196424T1 (de) Methode und zusammensetzung zur behandlung von herpes ähnlichen krankheiten
RU2000108989A (ru) Способ профилактики и лечения респираторных болезней телят
UA38388A (uk) Спосіб лікування епідемічного паротиту
SU1565027A1 (ru) Инактиватор вируса западного нила
UA32358A (uk) Спосіб лікування гіпертонічної хвороби серця
HUP9903911A2 (hu) PKC inhibitorok alkalmazása a központi idegrendszer HIV-fertőzéssel kapcsolatos megbetegedéseinek kezelésére szolgáló gyógyászati készítmények előállítására

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee